Global brain activity links subcortical degeneration to cortical tau progressively across Braak regions over early Alzheimer’s disease stages
Alzheimer’s disease (AD) is characterized by early tau pathology in subcortical neuromodulatory nuclei, followed by progressive cortical tau accumulation; however, the mechanisms linking subcortical dysfunction to cortical tau pathology remain unclear. Using multimodal neuroimaging data from the ADNI cohort, we examined how infra-slow ( < 0.1 Hz) global brain (i.e., gBOLD) activity is related to the volume of the nucleus basalis of Meynert (NbM) and cortical tau accumulation in the early stages of AD. NbM degeneration was associated with reduced gBOLD activity and spatially co-localized tau accumulation, appearing in early Braak regions during the preclinical stage, i.e., cognitively unimpaired participants with abnormal CSF markers, and extending to more advanced Braak areas during the prodromal stage, i.e., mild cognitive impairment (MCI) subjects. Our findings suggest that infra-slow gBOLD activity serves as a functional neural mediator linking subcortical degeneration to cortical tau pathology, highlighting a potential functional pathway linking subcortical and cortical pathology in early AD. This study finds that reduced infra-slow global brain activity may link degeneration of a key subcortical cholinergic region to progressive cortical tau accumulation in early Alzheimer’s disease.
Authors
- Xiao Liu (ORCID: https://orcid.org/0000-0002-8459-3135)
- Baizhou Pan
- Yutong Mao
Institutions
- Pennsylvania State University (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-09-12
- DOI
- https://doi.org/10.1038/s41467-026-77748-x
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Alzheimer's Association
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Biogen
- University of Southern California
- University of Pennsylvania
- F. Hoffmann-La Roche
- Meso Scale Diagnostics
- Alzheimer's Disease Neuroimaging Initiative
- BioClinica
- Novartis Pharmaceuticals Corporation
- Pennsylvania State University
- Northern California Institute for Research and Education
- Eisai
- Servier
- H. Lundbeck A/S
- IXICO
- National Institutes of Health
- Genentech
- Institute for Computational and Data Sciences, Pennsylvania State University
- Canadian Institutes of Health Research